Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients

Overview of attention for article published in Frontiers in immunology, January 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 117 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 44,933 followers.

RT @FrontImmunol: In this review, find how Visceral #Leishmaniasis #immunopathology is affected by #HIV #coinfection and potential new effe…

02 Dec 2019

Reply Repost Favourite

In this review, find how Visceral #Leishmaniasis #immunopathology is affected by #HIV #coinfection and potential new effective treatment strategy for coinfected patients #Immunology #openaccess @FrontImmunol: https://t.co/3fh62eaSJH https://t.co/cyzDpv4

02 Dec 2019

Reply Repost Favourite

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients, Wim Adriaensen et al https://t.co/j9qvCVW7Kf

16 Mar 2018

Reply Repost Favourite

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: Wim Adriaensen, Thomas P. C. Dorlo, Guido Vanham, Luc Kestens, Paul M. Kaye, Johan van Griensven https://t.co/gDD4tnpV3O

15 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.